EX-5.3 4 o34619exv5w3.htm CONSENT OF FASKEN MARTINEAU DUMOULIN LLP DATED FEBRUARY 5, 2007

exv5w3

Exhibit 5.3

February 5, 2007

Oncolytics Biotech Inc.
210, 1167 Kensington Crescent N.W.
Calgary, AB T2N 1X7

United States Securities and Exchange Commission

Ladies and Gentlemen:

Re:   Registration Statement on Form F-10

We hereby consent to the reference to us in the registration statement on Form F-10 (the “Registration Statement”) and the related preliminary short form prospectus (the “Prospectus”) of Oncolytics Biotech Inc. relating to the offering of units. We also consent to the use of our firm name on the cover page of the Prospectus and under the heading “Legal Matters”.

In giving this consent, we do not thereby admit that we come within the category of persons whose consent is required by the Securities Act of 1933 or the rules and regulations promulgated thereunder.

Yours truly,

FASKEN MARTINEAU DUMOULIN LLP
 
(Signed) “FASKEN MARTINEAU DUMOULIN LLP ”